insights_auto
Pourquoi RMD a-t-elle augmenté de 3,14%?
Approfondirchevron_right
RMD:NYSE
ResMed
227,64 $US
arrow_upward
+3,14%(+6,92) 1J
7 oct., 13:40:26 UTC−4 · USD
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour RMD...
Ouverture
222,27 $US
Élevé
228,75 $US
Faible
221,83 $US
Cap. boursière
32,02 Md
Vol. moyen
1,27 M
Volume
417,68 k
Dividende
1,16 %
Dividende trimestriel
0,66 $US
Date de détachement du dividende
20 août 2026
Ratio cours/bénéfice
21,83
+ haut sur 1 an
284,87 $US
+ bas sur 1 an
180,26 $US
BPA
10,43 $US
Bêta
0,75
Actions en circulation
140,64 M
Nombre d'employés
11 k
Ouverture
222,27 $US
Élevé
228,75 $US
Faible
221,83 $US
Cap. boursière
32,02 Md
Vol. moyen
1,27 M
Volume
417,68 k
Dividende
1,16 %
Dividende trimestriel
0,66 $US
Date de détachement du dividende
20 août 2026
Ratio cours/bénéfice
21,83
+ haut sur 1 an
284,87 $US
+ bas sur 1 an
180,26 $US
BPA
10,43 $US
Bêta
0,75
Actions en circulation
140,64 M
Nombre d'employés
11 k
Articles
Sources : Web et partenaires du secteur de l'information
Benzinga
·
il y a 47 minutes
Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
AD HOC NEWS
·
il y a 1 jour
ResMed plans USD 1.5 billion share repurchase and RBC raises target for ResMed stock
AD HOC NEWS
·
il y a 1 jour
ResMed stock pre-market at EUR 199.20: plus 0.48 percent
Profil
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
À propos de ResMed
PDGMichael J. Farrell
Employés11,4 k
Date de créationjuin 1989
Siège socialSan Diego, Californie, États-Unis
Secteur-
Site Webresmed.com